Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of Scleritis

In the present study, two female patients with unilateral scleritis without systemic complications were examined. Both patients were suffering from ocular pain and received corticosteroid therapy. The first patient, a 45-year-old woman, was diagnosed with scleritis and iritis in her right eye. Topic...

Full description

Bibliographic Details
Main Authors: Haruka Aoki, Miki Hiraoka, Masato Hashimoto, Hiroshi Ohguro
Format: Article
Language:English
Published: Karger Publishers 2015-05-01
Series:Case Reports in Ophthalmology
Subjects:
Online Access:http://www.karger.com/Article/FullText/430490
id doaj-acc182ba91f6484da5eeccafb76d0087
record_format Article
spelling doaj-acc182ba91f6484da5eeccafb76d00872020-11-25T00:34:44ZengKarger PublishersCase Reports in Ophthalmology1663-26992015-05-016214915710.1159/000430490430490Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of ScleritisHaruka AokiMiki HiraokaMasato HashimotoHiroshi OhguroIn the present study, two female patients with unilateral scleritis without systemic complications were examined. Both patients were suffering from ocular pain and received corticosteroid therapy. The first patient, a 45-year-old woman, was diagnosed with scleritis and iritis in her right eye. Topical corticosteroid treatment could eradicate the iritis but not the scleritis. Oral corticosteroid administration and corticosteroid pulse therapy were applied with little effect. The application of systemic cyclosporine had a satisfactory effect in controlling the scleritis. The other patient, a 60-year-old woman, was suffering from scleritis and lid swelling in her right eye. Not only did topical and systemic corticosteroid therapy prove insufficient, they also resulted in the elevation of her intraocular pressure. After termination of corticosteroid therapy, the systemic cyclosporine was applied orally. Subsequently, the patient's scleritis improved without any severe side effects. Scleritis is a painful and destructive inflammatory disease of the sclera that causes congestion of the scleral venous plexus. In this study, we have established a new grading system for assessing activity in scleritis that can score the extent of ocular pain and the area of congestion. This system provides a practical method for following the clinical course and monitoring the outcome of therapy. We report two cases of unilateral scleritis that were resistant to corticosteroid therapy but responsive to systemic administration of cyclosporine. Findings from these cases indicate that cyclosporine is an effective drug for controlling severe scleritis.http://www.karger.com/Article/FullText/430490Unilateral scleritisSystemic cyclosporine administrationScoring system
collection DOAJ
language English
format Article
sources DOAJ
author Haruka Aoki
Miki Hiraoka
Masato Hashimoto
Hiroshi Ohguro
spellingShingle Haruka Aoki
Miki Hiraoka
Masato Hashimoto
Hiroshi Ohguro
Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of Scleritis
Case Reports in Ophthalmology
Unilateral scleritis
Systemic cyclosporine administration
Scoring system
author_facet Haruka Aoki
Miki Hiraoka
Masato Hashimoto
Hiroshi Ohguro
author_sort Haruka Aoki
title Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of Scleritis
title_short Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of Scleritis
title_full Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of Scleritis
title_fullStr Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of Scleritis
title_full_unstemmed Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of Scleritis
title_sort systemic cyclosporine therapy for scleritis: a proposal of a novel system to assess the activity of scleritis
publisher Karger Publishers
series Case Reports in Ophthalmology
issn 1663-2699
publishDate 2015-05-01
description In the present study, two female patients with unilateral scleritis without systemic complications were examined. Both patients were suffering from ocular pain and received corticosteroid therapy. The first patient, a 45-year-old woman, was diagnosed with scleritis and iritis in her right eye. Topical corticosteroid treatment could eradicate the iritis but not the scleritis. Oral corticosteroid administration and corticosteroid pulse therapy were applied with little effect. The application of systemic cyclosporine had a satisfactory effect in controlling the scleritis. The other patient, a 60-year-old woman, was suffering from scleritis and lid swelling in her right eye. Not only did topical and systemic corticosteroid therapy prove insufficient, they also resulted in the elevation of her intraocular pressure. After termination of corticosteroid therapy, the systemic cyclosporine was applied orally. Subsequently, the patient's scleritis improved without any severe side effects. Scleritis is a painful and destructive inflammatory disease of the sclera that causes congestion of the scleral venous plexus. In this study, we have established a new grading system for assessing activity in scleritis that can score the extent of ocular pain and the area of congestion. This system provides a practical method for following the clinical course and monitoring the outcome of therapy. We report two cases of unilateral scleritis that were resistant to corticosteroid therapy but responsive to systemic administration of cyclosporine. Findings from these cases indicate that cyclosporine is an effective drug for controlling severe scleritis.
topic Unilateral scleritis
Systemic cyclosporine administration
Scoring system
url http://www.karger.com/Article/FullText/430490
work_keys_str_mv AT harukaaoki systemiccyclosporinetherapyforscleritisaproposalofanovelsystemtoassesstheactivityofscleritis
AT mikihiraoka systemiccyclosporinetherapyforscleritisaproposalofanovelsystemtoassesstheactivityofscleritis
AT masatohashimoto systemiccyclosporinetherapyforscleritisaproposalofanovelsystemtoassesstheactivityofscleritis
AT hiroshiohguro systemiccyclosporinetherapyforscleritisaproposalofanovelsystemtoassesstheactivityofscleritis
_version_ 1725311793772888064